ABSTRACT The presence of fluorescence was assessed in 34 unselected patients undergoing bronchoscopy, 11 of whom suffered from bronchial carcinoma. Bronchoscopic inspection was carried out with white light and then repeated with blue light after the injection of 2 ml of 10% sodium fluoresceinate. Fluorescence was graded visually. Seventy six pairs of biopsy specimens were obtained. Of 38 specimens from non fluorescent areas, histological appearances were normal in 34. Slight inflammation was observed in three biopsy specimens, and in one there was evidence of tumour even though the specimen was obtained some distance from the primary tumour. Of 38 biopsy specimens from fluorescent areas, histological examination showed appearances of moderate inflammation in 10, severe inflammation in 10, tuberculosis in one, and carcinoma in 11. In six instances histological appearances were normal. Five normal subjects who were smokers were also examined by the same technique. Appearances of metaplasia were found more often in areas showing fluorescence than in areas not showing fluorescence. Bronchial fluorescence is considered to be related to alteration in vascularity and is not specific for carcinoma. The most fluorescent areas are generally the most pathological and visible tumour is very fluorescent, but moderate degrees of fluorescence are difficult to interpret. Biopsy of every fluorescent area seems excessive.
excessive.
Fibreoptic bronchoscopy usually enables a histological diagnosis to be made in patients with proximal bronchogenic carcinoma. Small tumours, however, cannot be detected radiologically and invasion of the mucous membrane may be invisible at endoscopy. For some years now the use of fluorescent substances has been explored in an attempt to improve the localisation of these lesions. Fluorescent substances can be difficult to use. Tetracycline' 2 requires several days of preliminary treatment before bronchoscopy; the derivatives of haematoporphyrin3 injected into the veins give variable results, injection is required 48-96 hours before examination and there is a high risk of photosensitivity. Inhaling fluorescein4 has given good results but the technique is difficult and requires the use of a rigid bronchoscope and general anaesthesia.
We have devised a simple technique resembling that used by urologists-that could eventually be used routinely in fibreoptic bronchoscopy. We pres- (2) , obscure chest pain (1), cough (1) . Five healthy subjects volunteered to participate in a study of precancerous metaplasia. 4 Patients entered the study after their informed consent had been obtained.
In every subject in which a fluorescent area was seen at least two biopsy specimens were obtained (one from a fluorescent and one from a nonfluorescent area). The fluorescence was graded by two bronchoscopists, the grading being: intense fluorescence (+), slight fluorescence (±), and no fluorescence (-) . The pathologist was aware whether a specimen came from a fluorescent or a non-fluorescent area. Under white light the endoscopic appearances were divided into types: normal, visible tumour, and inflammation. The Societe Francaise de Pneumologie defines three stages of inflammation of the bronchial mucosa according to the thickness, colour, and vascular congestion and these criteria are used in this study.
The five men who volunteered to be examined with a view to detecting precancerous lesions (metaplasia) were healthy smokers; these subjects entered a larger study of 70 patients.7 They had had more than 15 pack years of smoking experience. Each underwent a careful examination by fibreoptic bronchoscopy, during which 10 biopsy specimens were taken on the 10 main bifurcations of the bronchial tree. The 
